Shanda Asset Management Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History

Shanda Asset Management Holdings’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-371,347	Closed	-$2.99M	–	27
2015 Q2	$2.99M	Buy	371,347 +1,793	+0.5%	+$13.2K	1.35%	18
2015 Q1	$2.43M	Hold	369,554	–	–	1.51%	11
2014 Q4	$2.35M	Buy	+369,554	New	+$2.98M	1.83%	9

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Shanda Asset Management Holdings's LXRX Position: Q3 2015 in Review

Shanda Asset Management Holdings sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2015, closing a stake of 371,347 shares — an estimated $2.99M sold.

Shanda Asset Management Holdings first reported a position in LXRX in Q4 2014 and held it in 3 quarters. The position peaked at $2.99M in Q2 2015. 105 funds tracked by Wall St. Rank hold LXRX as of Q3 2015.

Shanda Asset Management Holdings reported no remaining Lexicon Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Shanda Asset Management Holdings sold 371,347 Lexicon Pharmaceuticals shares in Q3 2015, an estimated $2.99M.
Shanda Asset Management Holdings first reported a position in Lexicon Pharmaceuticals in Q4 2014 and held it in 3 quarters.
Shanda Asset Management Holdings's Lexicon Pharmaceuticals position peaked at $2.99M in Q2 2015.
105 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2015.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2015, filed 16 Nov 2015.